The Structural Engineer > Archive > Volume 74 (1996) > Issues > Issue 21 > Discussion on Glaxo Wellcome Medicines Research Centre, Stevenage: Anatomy of the Design Process by
Name of File 6025-74-21.pdf cached at 11/12/2017 15:32:58 - with 4 pages. pdfPath: E:\k9.istructe.org\CMS\webtest\files\40\40b31107-39f7-4a77-a3d9-5658d6d2018a.pdf. thumbPath: E:\k9.istructe.org\CMS\webtest\files\pdfthumbs\40b31107-39f7-4a77-a3d9-5658d6d2018a_1.png. objDoc: 1 - True. objPreview.Log: . strFileName: 40b31107-39f7-4a77-a3d9-5658d6d2018a_1.png

Members/subscribers must be logged in to view this article

Discussion on Glaxo Wellcome Medicines Research Centre, Stevenage: Anatomy of the Design Process by Mr M.A. Barrie and Mr A.Jefcoat

Mr D. W. Wood (Sir Alexander Gibb & Partners) I wish to concentrate on two major areas. First, would the CDM Regulations have made a major impact on how you proceeded? Secondly, you said that the design evolved and then you implemented the changes. Can you explain the magnitude of the changes? Did you rip things out completely and start again or were they minor changes?